AMNEAL PHARMACEUTICALS, INC. Amortization of Debt Issuance Costs and Discounts
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Amortization of Debt Issuance Costs and Discounts of $7.95 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $4.06M, a 40.89% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $3.89M, a 42.89% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $3.71M, a 45.50% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $5.03M, a 37.34% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2025 was $22.43M, a 22.91% decline from fiscal 2024.
- AMNEAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2024 was $29.10M, a 151.97% increase from fiscal 2023.
- AMNEAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2023 was $11.55M, a 34.36% increase from fiscal 2022.
- AMNEAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2022 was $8.60M, a 6.61% decline from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 3 month as first filed | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 6 month as first filed | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 9 month as first filed | Amortization of Debt Issuance Costs and Discounts 12 month | Amortization of Debt Issuance Costs and Discounts 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.95M 10-Q · filed 2026-08-06 | $11.67M derived: sum of 3 quarters · filed 2026-08-06 | $16.70M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $3.89M 10-Q · filed 2026-05-07 | $7.61M derived: sum of 2 quarters · filed 2026-05-07 | $12.63M derived: sum of 3 quarters · filed 2026-05-07 | $19.51M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $8.74M derived: sum of 2 quarters · filed 2026-02-27 | $15.62M derived: sum of 3 quarters · filed 2026-08-06 | $22.43M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $5.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $11.90M derived: sum of 2 quarters · filed 2026-08-06 | $18.72M 10-Q · filed 2025-11-06 | $25.53M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $6.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $13.69M 10-Q · filed 2026-08-06 | $20.50M derived: sum of 3 quarters · filed 2026-08-06 | $28.53M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $6.81M 10-Q · filed 2026-05-07 | $13.63M derived: sum of 2 quarters · filed 2026-05-07 | $21.66M derived: sum of 3 quarters · filed 2026-05-07 | $29.11M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $14.85M derived: sum of 2 quarters · filed 2026-02-27 | $22.29M derived: sum of 3 quarters · filed 2026-02-27 | $29.10M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $8.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $15.48M derived: sum of 2 quarters · filed 2025-11-06 | $22.28M 10-Q · filed 2025-11-06 | $2.66M 10-Q · filed 2024-11-12 | $26.94M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-06-30 | $7.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $14.25M 10-Q · filed 2025-08-07 | $1.22M 10-Q · filed 2024-08-09 | $18.92M derived: sum of 3 quarters · filed 2026-02-27 | $21.28M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-03-31 | $6.80M 10-Q · filed 2025-05-07 | $288.00K 10-Q · filed 2024-05-08 | $11.47M derived: sum of 2 quarters · filed 2026-02-27 | $13.83M derived: sum of 3 quarters · filed 2026-02-27 | $16.29M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2023-12-31 | $4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $7.03M derived: sum of 2 quarters · filed 2026-02-27 | $9.49M derived: sum of 3 quarters · filed 2026-02-27 | $11.55M 10-K · filed 2026-02-27 | $8.18M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | $2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.83M derived: sum of 2 quarters · filed 2024-11-12 | $6.88M 10-Q · filed 2024-11-12 | $8.99M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $4.52M 10-Q · filed 2024-08-09 | $6.63M derived: sum of 3 quarters · filed 2025-02-28 | $8.73M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $2.06M 10-Q · filed 2024-05-08 | $4.16M derived: sum of 2 quarters · filed 2025-02-28 | $6.26M derived: sum of 3 quarters · filed 2025-02-28 | $8.46M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $4.21M derived: sum of 2 quarters · filed 2025-02-28 | $6.40M derived: sum of 3 quarters · filed 2025-02-28 | $8.60M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $4.29M derived: sum of 2 quarters · filed 2023-11-09 | $6.49M 10-Q · filed 2023-11-09 | $8.82M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $4.39M 10-Q · filed 2023-08-08 | $6.72M derived: sum of 3 quarters · filed 2024-03-14 | $9.12M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-03-31 | $2.19M 10-Q · filed 2023-05-09 | $4.53M derived: sum of 2 quarters · filed 2024-03-14 | $6.92M derived: sum of 3 quarters · filed 2024-03-14 | $9.21M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2021-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $4.73M derived: sum of 2 quarters · filed 2024-03-14 | $7.02M derived: sum of 3 quarters · filed 2024-03-14 | $9.20M 10-K · filed 2024-03-14 | ||||
| 2021-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $4.69M derived: sum of 2 quarters · filed 2022-11-07 | $6.87M 10-Q · filed 2022-11-07 | $9.10M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-06-30 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $4.47M 10-Q · filed 2022-08-08 | $6.70M derived: sum of 3 quarters · filed 2023-03-03 | $8.94M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-03-31 | $2.18M 10-Q · filed 2022-05-06 | $4.41M derived: sum of 2 quarters · filed 2023-03-03 | $6.65M derived: sum of 3 quarters · filed 2023-03-03 | $8.86M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2020-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $4.46M derived: sum of 2 quarters · filed 2023-03-03 | $6.67M derived: sum of 3 quarters · filed 2023-03-03 | $8.68M 10-K · filed 2023-03-03 | ||||
| 2020-09-30 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $4.45M derived: sum of 2 quarters · filed 2021-11-08 | $6.45M 10-Q · filed 2021-11-08 | |||||
| 2020-06-30 | $2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $4.21M 10-Q · filed 2021-08-09 | ||||||
| 2020-03-31 | $2.00M 10-Q · filed 2021-05-07 | |||||||
| 2019-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.25M derived: sum of 2 quarters · filed 2020-11-06 | $4.85M 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.22M 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | $1.60M 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |